Panagora Asset Management Inc. cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 130,165 shares of the pharmacy operator’s stock after selling 3,719 shares during the period. Panagora Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $6,848,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently bought and sold shares of the company. Stonebridge Capital Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Loomis Sayles & Co. L P purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $33,000. Red Door Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $35,000. Centerpoint Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 203.8% in the second quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 477 shares in the last quarter. Finally, Better Money Decisions LLC grew its holdings in Walgreens Boots Alliance by 213.5% during the second quarter. Better Money Decisions LLC now owns 790 shares of the pharmacy operator’s stock worth $42,000 after acquiring an additional 538 shares during the period. Hedge funds and other institutional investors own 55.65% of the company’s stock.
A number of equities analysts have recently weighed in on the stock. TheStreet cut shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Friday, June 18th. Robert W. Baird reissued a “buy” rating and set a $68.00 price objective on shares of Walgreens Boots Alliance in a report on Friday, September 3rd. Credit Suisse Group dropped their target price on shares of Walgreens Boots Alliance from $50.00 to $48.00 and set a “neutral” rating for the company in a report on Friday, July 2nd. Barclays reduced their price target on shares of Walgreens Boots Alliance from $55.00 to $53.00 and set an “equal weight” rating for the company in a research report on Tuesday, July 6th. Finally, Truist lowered their price target on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a report on Friday, July 2nd. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $50.83.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.17 by $0.21. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The company had revenue of $34.03 billion during the quarter, compared to the consensus estimate of $33.47 billion. During the same period in the previous year, the firm posted $0.71 EPS. Walgreens Boots Alliance’s revenue was up 12.1% on a year-over-year basis. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 10th. Shareholders of record on Friday, August 20th were paid a $0.477 dividend. This represents a $1.91 dividend on an annualized basis and a yield of 3.97%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. The ex-dividend date of this dividend was Thursday, August 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.
Featured Story: Understanding Average Daily Trade Volume
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.